,i #aahth ,,congress #b;d ,session ,h4 ,r4 #hija ,,in ,,the ,,house ,,of ,,representatives ,june #bh1 #bjbd ,mr4 ,peters 7for himself1 ,mr4 ,joyce of ,ohio1 ,mr4 ,thanedar1 and ,mrs4 ,chavez-,de,remer7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committee on the ,judiciary1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to amend the ,public ,health ,service ,act to provide for the designation of institutions of higher education as ,centers of ,excellence in ,cannabis ,research1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,cannabis ,research ,act4 #b4 ,cannabis research at the ,department of ,health and ,human ,services 7a7 ,national cannabis research agenda ,part ,b of title ,,iv of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bhd et seq47 is amended by adding at the end the following3 #dji,k4 ,national cannabis research agenda 7a7 ,in general ,not later than #a year after the date of enactment of the ,cannabis ,research ,act1 the ,director of ,,nih1 in collaboration with the ,director of the ,centers for ,disease ,control and ,prevention1 the ,commissioner of ,food and ,drugs1 and the ,assistant ,secretary for ,mental ,health and ,substance ,use1 shall develop a national cannabis research agenda that addresses key questions and gaps in evidence1 including with respect to each of the following3 7#a7 ,the safety and efficacy of cannabis in providing therapeutic benefits for certain priority diseases or conditions1 which may include epilepsy1 multiple sclerosis-related spasticity1 chemotherapy-induced pain and discomfort1 using cannabis as an alternative to opioid analgesics for acute or chronic pain1 sleep apnea1 ,tourette syndrome1 anxiety1 post-traumatic stress disorder1 and any other disease or condition determined to be appropriate and of importance by the ,director4 7#b7 ,the effect of cannabis on at-risk populations1 including children1 older individuals1 and pregnant or breast-feeding women4 7#c7 ,the nontherapeutic impacts of cannabis use in the short-term and long-term4 7#d7 ,the long-term effects of cannabis use1 including dose-response relationship and the connection between cannabis use and behavioral health4 7#e7 ,the clinically appropriate dosages and modes of delivery of cannabis4 7#f7 ,public safety considerations related to cannabis1 including-- 7,a7 variation in the potency of cannabis products2 7,b7 youth access to and use of cannabis1 including marketing1 packaging1 edible formulations1 and flavor options that target youth2 7,c7 risk factors for cannabis misuse2 7,d7 impaired driving related to cannabis use2 7,e7 accidental ingestion of cannabis2 and 7,f7 relative risk of cannabis as compared to alcohol and tobacco4 7b7 ,definition ,in this section1 the term cannabis means all parts of the plant ,cannabis sativa ,l41 whether growing or not2 the seeds thereof2 the resin extracted from any part of such plant2 and every compound1 manufacture1 salt1 derivative1 mixture1 or preparation of such plant1 its seeds1 or its resin4 4 7b7 ,surveillance activities ,part ,a of title ,,iii of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bda et seq47 is amended by adding at the end the following3 #caj;,c4 ,surveillance activities on cannabis use 7a7 ,in general ,the ,secretary1 acting through the ,director of the ,centers for ,disease ,control and ,prevention1 in collaboration with the ,assistant ,secretary for ,mental ,health and ,substance ,use1 the ,administrator of the ,centers for ,medicare ,medicaid ,services1 and the ,director of the ,agency for ,healthcare ,research and ,quality1 shall carry out surveillance activities to collect population-wide data on cannabis use4 7b7 ,permissible activities 7#a7 ,in general ,in carrying out activities under this section1 the ,secretary may collect1 as appropriate1 with respect to cannabis use-- 7,a7 data on-- 7i7 health outcomes1 including biological data2 7ii7 health care utilization1 which shall include hospitalizations and utilization of emergency departments related to consumption of cannabis1 including among youth2 7iii7 demographic factors associated with cannabis use2 7iv7 the variety of products and delivery modes used2 and 7v7 other relevant health information to improve the understanding of cannabis use in all age groups and sub-populations2 and 7,b7 data through public health surveillance systems1 surveys1 questionnaires1 and databases of health care records1 including1 as appropriate1 the ,behavioral ,risk ,factor ,surveillance ,system1 the ,youth ,risk ,behavioral ,surveillance ,system1 the ,monitoring the ,future health survey1 the ,national ,survey on ,drug ,use and ,health1 or the ,healthcare ,cost and ,utilization ,project 7or any successor surveys74 7#b7 ,privacy ,any data collected under paragraph 7#a7 shall be collected in a manner that protects personal privacy to the extent1 at a minimum1 that is required under applicable ,federal and ,state law4 7c7 ,definition ,in this section1 the term cannabis means all parts of the plant ,cannabis sativa ,l41 whether growing or not2 the seeds thereof2 the resin extracted from any part of such plant2 and every compound1 manufacture1 salt1 derivative1 mixture1 or preparation of such plant1 its seeds1 or its resin4 4 #c4 ,centers of ,excellence in ,cannabis ,research 7a7 ,in general ,part ,b of title ,,iv of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bhd et seq471 as amended by section #b1 is further amended by adding at the end the following3 #dji,l4 ,centers of ,excellence in ,cannabis ,research 7a7 ,designation 7#a7 ,in general ,the ,director of ,,nih shall designate institutions of higher education as ,centers of ,excellence in ,cannabis ,research for the purpose of interdisciplinary research related to cannabis and other biomedical1 behavioral1 and social issues related to cannabis4 7#b7 ,application ,to be designated as a ,center of ,excellence in ,cannabis ,research1 an institution of higher education shall submit an application to1 and receive approval from1 the ,director of ,,nih4 ,such an application shall be submitted in such manner and contain such information as the ,director of ,,nih may reasonably require4 ,the ,director of ,,nih may not approve such an application unless-- 7,a7 the application contains or is supported by reasonable assurances that-- 7i7 the applicant has the experience1 or capability-- 7,i7 to conduct1 through biomedical1 behavioral1 social1 and related disciplines1 long-term research on cannabis2 and 7,,ii7 to provide coordination of such research among such disciplines2 7ii7 the applicant has available to it sufficient personnel and facilities 7including laboratory1 reference1 storage1 security1 and data analysis facilities7 to carry out the research plan required under subparagraph 7,b72 7iii7 the applicant has the capacity to conduct academic courses and train students and professionals on appropriate research and knowledge of cannabis2 and 7iv7 the applicant will secure ,state funds for research related to cannabis to complement any ,federal funds for such research under this section2 and 7,b7 the application contains a detailed #e-year plan for research relating to cannabis4 7#c7 ,priority ,in selecting institutions of higher education for designation as ,centers of ,excellence in ,cannabis ,research1 the ,director of ,,nih shall give priority to such institutions that have proven track records in medicinal cannabis research4 7#d7 ,geographic representation ,the ,director of ,,nih shall1 to the extent practicable1 ensure geographic representation across the ,united ,states in designating institutions of higher education as ,centers of ,excellence in ,cannabis ,research4 7#e7 ,term of designation ,a designation under this section shall be for a period of #e years1 so long as the institution of higher education continues to meet the requirements of paragraph 7#b74 ,an institution of higher education may reapply in accordance with the requirements of paragraph 7#b7 for a subsequent designation under this section4 7b7 ,cannabis research 7#a7 ,grants or cooperative agreements 7,a7 ,in general ,the ,director of ,,nih may make grants to1 or enter into cooperative agreements with1 #aj ,centers that have been designated under this section to expand the current and ongoing interdisciplinary research and clinical trials relating to cannabis research4 7,b7 ,authorization of appropriations ,to carry out this paragraph1 there is authorized to be appropriated #ej1jjj1jjj for each of fiscal years #bjbf through #bjcj4 7#b7 ,research results ,the ,director of ,,nih shall promptly disseminate research results under this subsection to relevant governmental1 academic1 and research entities4 7c7 ,definitions ,in this section3 7#a7 ,the term cannabis means all parts of the plant ,cannabis sativa ,l41 whether growing or not2 the seeds thereof2 the resin extracted from any part of such plant2 and every compound1 manufacture1 salt1 derivative1 mixture1 or preparation of such plant1 its seeds1 or its resin4 7#b7 ,the term institution of higher education has the meaning given the term in section #aja7;a7 of the ,higher ,education ,act of #aife4 4 7b7 ,registration requirements ,section #cjc of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbc7 is amended by adding at the end the following3 7m7 ,registration of practitioners at ,centers of ,excellence in ,cannabis ,research 7#a7 ,in general ,the ,attorney ,general shall register under subsection 7f7 practitioners at ,centers of ,excellence in ,cannabis ,research designated under section #dji,l of the ,public ,health ,service ,act to conduct research with marijuana4 7#b7 ,testing of constituents ,to the extent a ,center of ,excellence in ,cannabis ,research in a ,state tests marijuana products that are lawfully available for such testing in such ,state for cannabinoid and noncannabinoid constituents1 no sanction under this title shall apply to such testing1 including the acquisition of such products for such testing4 7#c7 ,use of marijuana products under ,state law ,no sanction under this title shall apply to the acquisition or use of marijuana products for a clinical trial or other research to the extent such clinical trial or other research is conducted-- 7,a7 to further the goals of the national cannabis research agenda under section #dji,k2 and 7,b7 at a ,center of ,excellence in ,cannabis ,research in a ,state using marijuana products that are lawfully available for such purpose under laws of the ,state4 7#d7 ,definition ,in this subsection1 the term ,center of ,excellence in ,cannabis ,research means a ,center of ,excellence in ,cannabis ,research for which a designation is in effect under section #dji,l7a7 of the ,public ,health ,service ,act4 4